ArticleActa oncologica (Stockholm, Sweden)2026
The Clinical outcomes following pencil beam scanning proton therapy for skull base chordoma and chondrosarcoma: a single-institution experience.
Article in Acta oncologica (Stockholm, Sweden), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChordomas and chondrosarcomas of the skull base are rare, locally aggressive tumors that pose significant therapeutic challenges due to their proximity to critical anatomical structures. While maximal safe surgical resection remains the cornerstone of management, the infiltrative nature of these tumors often precludes radical excision, necessitating adjuvant radiotherapy. Given their relative radioresistance, high-dose radiotherapy exceeding 70 Gray Relative Biological Effectiveness (GyRBE) is required to achieve durable local control. This study evaluated long-term outcomes and toxicity following pencil beam scanning (PBS) proton therapy in patients with skull base chordoma and chondrosarcoma.
methodsWe retrospectively analyzed 76 patients (50 chordoma, 26 chondrosarcoma) treated with curative-intent PBS between 2016 and 2020. Median prescribed doses were 74.0 GyRBE for chordomas and 70.0 GyRBE for chondrosarcomas. Clinical endpoints included overall survival (OS), local failure-free survival (LFFS), distant metastasis-free survival (DMFS), and toxicity graded according to CTCAE v5.0.
resultsAt a median follow-up of 70.2 months, 5-year OS, LFFS, and DMFS for the entire cohort were 84.0, 86.9, and 92.7%, respectively. Local control was numerically higher in chondrosarcoma (96.1%) than in chordoma (81.9%; p = 0.116). Tumor contact with the optic apparatus or brainstem was associated with worse OS (p = 0.0034 and p = 0.0151, respectively) and proximity to the optic pathways correlated with poorer local control (p = 0.0182). Grade ≥ 3 late toxicity occurred in 9.2% of patients, predominantly hearing impairment and temporal lobe necrosis.
conclusionsPBS achieves excellent local control and survival with an acceptable safety profile in skull base chordoma and chondrosarcoma. Our findings align with ongoing efforts toward dose intensification, hypofractionation, and particle selection. Moreover, emerging integration of artificial intelligence for contouring, treatment adaptation, and toxicity prediction, along with augmented reality-assisted positioning and patient education, promises to further enhance treatment precision and outcomes. Through long-term follow-up and engagement with international research initiatives, our institution contributes to the global advancement of biologically guided, high-precision radiotherapy for rare skull base malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.